Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Resmed Inc NYSE: RMD-N

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 199.01
Day High 202.97
Open:199.56
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Sleep Tech Devices Market Value Could Exceed $31 Billion By 2026
- PR Newswire - PRF - Tue Feb 23, 1:14PM CST
PR Newswire - PRF - CMTX
Tue Feb 23, 1:14PM CST
PALM BEACH,  Fla., /PRNewswire/ -- Changing lifestyle, consumption of junk food and lack of exercise have disturbed the normal metabolism of an individual's body ultimately increasing the prevalence of sleeping disorders such as obstructive sleep apnea, narcolepsy, insomnia, etc. Thus, there has been an increase in the demand for sleep tech devices that enhances the sleep activity in individuals suffering from sleep-related disorders. Technological advancements in sleep tech devices will prove beneficial for industry growth. Innovations introduced within these sleep devices have enhanced the comfort levels in individuals suffering from chronic disorders. Currently available sleep devices effectively monitor and provide overall analysis that enables people to optimize their sleep patterns. Hence, growing availability of advanced sleep tech wearables and devices for treating sleep diseases will escalate the industry growth. Reports have continually expressed an increase in revenues for the sleep Tech devices markets over the past few years. At the end of 2019, a  from Global Markets Insights said that Sleep Tech Devices Market Value To Reach By 2025 With A CAGR Of 16% "propelled by favorable demographic trends coupled with rising awareness regarding availability of advanced sleep tech devices." An updated report 1 year later, predicted an increase saying that: "the market valuation of sleep tech devices will cross $32 billion by 2026. Rising awareness regarding availability of sleep tech devices in developed and developing countries will elevate the market growth during the forecast period."   Active companies in the markets this week include (OTCQB: HAPBF) (TSX-V: HAPB) (NYSE: CSPR), (NYSE: RMD), (NASDAQ: SNBR), (NYSE: TPX).  Some of the major findings in their reports were that Increasing prevalence of sleeping disorders will positively impact the sleep tech devices market growth over the analysis timeframe; Individuals suffering from insomnia and sleep apnea have high inclination towards wearable sleep tracking devices; Changing lifestyle and intake of unhealthy dietary supplements has escalated the anxiety and depression rate amongst youths that elevates the demand for sleep aid and diagnostics devices; and Availability of innovative and technological advanced sleep tech devices will surge its demand especially in developed countries.
Sleep Tech Devices Market Value Could Exceed $31 Billion By 2026
- PR Newswire - PRF - Tue Feb 23, 7:45AM CST
PR Newswire - PRF - CMTX
Tue Feb 23, 7:45AM CST
PALM BEACH,  Fla., /PRNewswire/ -- Changing lifestyle, consumption of junk food and lack of exercise have disturbed the normal metabolism of an individual's body ultimately increasing the prevalence of sleeping disorders such as obstructive sleep apnea, narcolepsy, insomnia, etc. Thus, there has been an increase in the demand for sleep tech devices that enhances the sleep activity in individuals suffering from sleep-related disorders. Technological advancements in sleep tech devices will prove beneficial for industry growth. Innovations introduced within these sleep devices have enhanced the comfort levels in individuals suffering from chronic disorders. Currently available sleep devices effectively monitor and provide overall analysis that enables people to optimize their sleep patterns. Hence, growing availability of advanced sleep tech wearables and devices for treating sleep diseases will escalate the industry growth. Reports have continually expressed an increase in revenues for the sleep Tech devices markets over the past few years. At the end of 2019, a  from Global Markets Insights said that Sleep Tech Devices Market Value To Reach By 2025 With A CAGR Of 16% "propelled by favorable demographic trends coupled with rising awareness regarding availability of advanced sleep tech devices." An updated report 1 year later, predicted an increase saying that: "the market valuation of sleep tech devices will cross $32 billion by 2026. Rising awareness regarding availability of sleep tech devices in developed and developing countries will elevate the market growth during the forecast period."   Active companies in the markets this week include (OTCQB: HAPBF) (TSX-V: HAPB) (NYSE: CSPR), (NYSE: RMD), (NASDAQ: SNBR), (NYSE: TPX).
MatrixCare Home Health EHR Solution Wins Best in KLAS - Again
- BusinessWire - Tue Feb 2, 8:08AM CST
BusinessWire - CMTX
Tue Feb 2, 8:08AM CST
MatrixCare announced today its Home Health and Hospice EHR solution has won Best in KLAS for Home Health EHR (Large) from KLAS Research for the second year in a row.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 191.10 +5.16% increase
on 02/17/21
Period Open:215.52
Price movement based on the high, low and last over the given period.
224.43 -10.45% decrease
on 01/26/21
-14.55 (-6.75%) decrease
since 01/22/21
3-Month 191.10 +5.16% increase
on 02/17/21
Period Open:206.53
Price movement based on the high, low and last over the given period.
224.43 -10.45% decrease
on 01/26/21
-5.56 (-2.69%) decrease
since 11/24/20
52-Week 108.85 +84.63% increase
on 03/23/20
Period Open:169.83
Price movement based on the high, low and last over the given period.
224.43 -10.45% decrease
on 01/26/21
+31.14 (+18.34%) increase
since 02/24/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies